Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
3.990
+0.100 (2.57%)
At close: Jul 31, 2026, 4:00 PM EDT
3.900
-0.090 (-2.26%)
After-hours: Jul 31, 2026, 6:26 PM EDT
Bolt Biotherapeutics Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Bolt Biotherapeutics stock has a consensus rating of "Buy" and an average price target of $41. The average 1-year stock price forecast is 927.57% higher than the current stock price, while the lowest is $7.00 (+75.44%) and the highest is $75 (+1,779.70%).
Price Target: $41 (+927.57%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on May 28, 2026.
Analyst Ratings
The average analyst rating for Bolt Biotherapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Buy | 0 | 1 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 3 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JonesTrading | JonesTrading | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Jun 25, 2026 |
| Rodman & Renshaw | Rodman & Renshaw | Buy Initiates $22 | Buy | Initiates | $22 | +451.38% | May 28, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $7 | Buy | Reiterates | $7 | +75.44% | May 28, 2026 |
| Lake Street | Lake Street | Buy Maintains $75 | Buy | Maintains | $75 | +1,779.70% | May 13, 2026 |
Financial Forecast
Revenue This Year
1.51M
from 7.70M
Decreased by -80.39%
Revenue Next Year
3.50M
from 1.51M
Increased by 131.99%
EPS This Year
-238.28
from -17.06
EPS Next Year
-254.96
from -238.28
EPS and Forward PE are based on non-GAAP adjusted numbers.